We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

29 hedge funds and large institutions have $48.3M invested in OptimizeRx in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,600% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 1

127% more capital invested

Capital invested by funds: $21.3M → $48.3M (+$27M)

123% more funds holding

Funds holding: 13 → 29 (+16)

5.33% more ownership

Funds ownership: 17.71% → 23.04% (+5.3%)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
29
Holders Change
+16
Holders Change %
+123.08%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
1
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.64M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.07M
3
Millennium Management
Millennium Management
New York
+$1.07M
4
DCM
Driehaus Capital Management
Illinois
+$932K
5
TCM
Timpani Capital Management
Wisconsin
+$903K

Top Sellers

1
WAM
Wolverine Asset Management
Illinois
-$1.23M
2
PWAM
Park West Asset Management
California
-$1.06M
3
VCM
Venator Capital Management
Ontario, Canada
-$147K
4
FIA
FNY Investment Advisers
New York
-$118K
5
FM
Family Management
New York
-$54.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
26
IFP Advisors
Florida
$28K +$19.5K +1,550 New
TRCT
27
Tower Research Capital (TRC)
New York
$20K +$14.1K +1,117 New
Deutsche Bank
28
Deutsche Bank
Germany
$10K +$6.93K +550 New
PCM
29
Prelude Capital Management
New York
$3K +$1.88K +149 New
FIA
30
FNY Investment Advisers
New York
– -$118K -11,400 Closed
1
2

OPRX Hedge Fund Activity: Q3 2018 in Review

29 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q3 2018, worth a combined $48.3M — up 127% from $21.3M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new OPRX positions and 1 closed out — a net gain of 16 holders — while 1 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $3.64M. The largest seller was Wolverine Asset Management, cutting an estimated $1.23M.

  • 29 institutional investors held OptimizeRx (OPRX) as of Q3 2018, up from 13 in Q2 2018.
  • Funds reported $48.3M of OptimizeRx stock for Q3 2018, up 127% quarter-over-quarter.
  • 17 funds opened new OptimizeRx positions in Q3 2018 and 1 closed out, a net change of +16 holders.
  • The largest OptimizeRx buyer in Q3 2018 was Vanguard Group, an estimated $3.64M added.
  • The largest OptimizeRx seller in Q3 2018 was Wolverine Asset Management, an estimated $1.23M sold.

Based on aggregated 13F filings for Q3 2018.